Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differentiated thyroid cancers: a comprehensive review of novel targeted therapies.

Expert review of anticancer therapy - 1 Mar 2012

Kojic Katarina L, Kojic Stefan L, Wiseman Sam M

Abstract excerpt

Differentiated thyroid carcinoma (DTC) accounts for more than 90% of new thyroid cancer diagnoses, and includes papillary, follicular and Hürthle cell carcinoma. The prognosis for the vast majority of individuals diagnosed with DTC is excellent, with current treatment that includes surgery, radioactive iodine ablation and postoperative thyroid-stimulating hormone suppression. Unfortunately, the small proportion...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiogenesis Inhibitors
Share to Carcinoma
Share to Cell Dedifferentiation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clinical Trials, Phase II as Topic

Share to Disease Resistance

Share to Neovascularization, Pathologic

Share to Proto-Oncogene Proteins c-ret

Share to Thyroid Gland

Source

Identifiers

PMID: 22369326
DOI: 10.1586/era.12.8

Genes

BRAF
RET

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differentiated thyroid cancers: a comprehensive review of novel targeted therapies.PMID 22369326Read ↗

New Therapies for Advanced Thyroid Cancer.Semantic proximity Read ↗

Clinical and Translational Challenges in Thyroid Cancer.Semantic proximity Read ↗

Updates on the Management of Thyroid Cancer.Semantic proximity Read ↗

Novel targeted therapies and immunotherapy for advanced thyroid cancers.Semantic proximity Read ↗

Progress in Treating Advanced Thyroid Cancers in the Era of Targeted Therapy.Semantic proximity Read ↗

Update on the molecular diagnosis and targeted therapy of thyroid cancer.Semantic proximity Read ↗

Evolving molecularly targeted therapies for advanced-stage thyroid cancers.Semantic proximity Read ↗

Targeted therapy in thyroid cancer: molecular alterations and clinical management.Semantic proximity Read ↗

The Role of the Kinase Inhibitors in Thyroid CancersSemantic proximity Read ↗

Thyroid cancer in 2010: a roadmap for targeted therapies.Semantic proximity Read ↗

Advances and challenges in thyroid cancer: The interplay of genetic modulators, targeted therapies, and AI-driven approachesSemantic proximity Read ↗

Molecular genetics, therapeutics and RET inhibitor resistance for medullary thyroid carcinoma and future perspectivesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.